Palisade Bio, Inc. SEC filings PALI
Palisade Bio, Inc. has 1,000 filings in SEC EDGAR's recent list, going back to Nov 16, 2011. Its latest annual report, Form ARS, was filed on Apr 29, 2026 for the period ended Dec 31, 2025. The latest quarterly report (Form 10-Q) was filed on Aug 10, 2026, covering the quarter ended Jun 30, 2026. The most recent current report (Form 8-K) was filed on Aug 10, 2026 (results of operations). The company's fiscal year ends on December 31.
| Form | Description | Filed | Period |
|---|---|---|---|
| DEFA14A | Additional proxy material | Apr 29, 2026 | — |
| DEF 14A | Proxy statement | Apr 29, 2026 | Apr 29, 2026 |
| PRE 14A | Preliminary proxy statement | Apr 17, 2026 | Apr 17, 2026 |
| DEFA14A | Additional proxy material | Nov 3, 2025 | — |
| DEF 14A | Proxy statement | Oct 28, 2025 | Oct 28, 2025 |
| PRE 14A | Preliminary proxy statement | Oct 17, 2025 | Oct 17, 2025 |
| DEFA14A | Additional proxy material | Oct 7, 2025 | — |
| DEF 14A | Proxy statement | Sep 15, 2025 | Sep 15, 2025 |
| DEFA14A | Additional proxy material | Sep 15, 2025 | — |
| PRE 14A | Preliminary proxy statement | Sep 5, 2025 | Sep 5, 2025 |
| DEF 14A | Proxy statement | Aug 18, 2025 | Aug 18, 2025 |
| PRE 14A | Preliminary proxy statement | Aug 6, 2025 | Aug 6, 2025 |
| DEFA14A | Additional proxy material | May 22, 2024 | — |
| DEF 14A | Proxy statement | May 22, 2024 | May 22, 2024 |
| DEFA14A | Additional proxy material | Feb 6, 2024 | — |
| DEF 14A | Proxy statement | Feb 6, 2024 | Feb 6, 2024 |
| PRE 14A | Preliminary proxy statement | Jan 26, 2024 | Jan 26, 2024 |
| DEFA14A | Additional proxy material | Apr 21, 2023 | — |
| DEF 14A | Proxy statement | Apr 21, 2023 | Apr 21, 2023 |
| DEF 14A | Proxy statement | Aug 31, 2022 | Aug 31, 2022 |
| DEF 14A | Proxy statement | Aug 31, 2022 | Aug 31, 2022 |
| PRE 14A | Preliminary proxy statement | Aug 22, 2022 | Aug 22, 2022 |
| PRE 14A | Preliminary proxy statement | Aug 22, 2022 | Aug 22, 2022 |
| DEFA14A | Additional proxy material | Apr 21, 2022 | — |
| DEF 14A | Proxy statement | Apr 21, 2022 | Jun 9, 2022 |
| DEFA14A | Additional proxy material | Oct 7, 2021 | — |
| DEF 14A | Proxy statement | Oct 7, 2021 | Nov 18, 2021 |
| DEFA14A | Additional proxy material | Sep 2, 2020 | — |
| DEFA14A | Additional proxy material | Aug 21, 2020 | — |
| DEFA14A | Additional proxy material | Aug 20, 2020 | — |
| DEFA14A | Additional proxy material | Aug 10, 2020 | — |
| DEFA14A | Additional proxy material | Jun 24, 2020 | — |
| DEF 14A | Proxy statement | Jun 24, 2020 | Aug 7, 2020 |
| PRE 14A | Preliminary proxy statement | Jun 12, 2020 | Jun 9, 2020 |
| DEFA14A | Additional proxy material | Apr 29, 2019 | — |
| DEF 14A | Proxy statement | Apr 29, 2019 | Jun 12, 2019 |
| PRE 14A | Preliminary proxy statement | Apr 19, 2019 | Apr 19, 2019 |
| DEFA14A | Additional proxy material | Apr 25, 2018 | — |
| DEF 14A | Proxy statement | Apr 25, 2018 | Jun 11, 2018 |
| DEFA14A | Additional proxy material | May 1, 2017 | — |
| DEF 14A | Proxy statement | May 1, 2017 | Jun 22, 2017 |
| DEF 14A | Proxy statement | Aug 1, 2016 | Aug 29, 2016 |
| PRE 14A | Preliminary proxy statement | Jul 21, 2016 | Jul 18, 2016 |
| DEFA14A | Additional proxy material | Apr 28, 2016 | — |
| DEF 14A | Proxy statement | Apr 28, 2016 | Jun 17, 2016 |
| DEFA14A | Additional proxy material | Apr 27, 2015 | — |
| DEF 14A | Proxy statement | Apr 27, 2015 | Jun 19, 2015 |
| DEFA14A | Additional proxy material | Apr 29, 2014 | — |
| DEF 14A | Proxy statement | Apr 29, 2014 | Jun 27, 2014 |
| PRE 14A | Preliminary proxy statement | Apr 18, 2014 | Apr 18, 2014 |
| DEFA14A | Additional proxy material | Apr 30, 2013 | — |
| DEF 14A | Proxy statement | Apr 30, 2013 | Jun 21, 2013 |
| DEF 14A | Proxy statement | Apr 30, 2012 | Jun 19, 2012 |
Showing 53 filings. Main filings leave out insider and ownership forms such as Form 4; choose a type above to see them. Each form opens on SEC.gov. Older filings are on SEC EDGAR.
New to this? Read What Are SEC Filings? 10-K, 10-Q, 8-K and Other Forms Explained.
Company profile
- Industry
- Biological Products, (No Diagnostic Substances) (SIC 2836)
- Listed as
- PALI (Nasdaq)
- Fiscal year ends
- December 31
- Incorporated in
- DE
- Headquarters
- Carlsbad, CA
- SEC filer status
- Non-accelerated filer, Smaller reporting company
- SEC CIK
- 1357459
- Former names
- PALISADE BIO, INC. (until Oct 30, 2026); Seneca Biopharma, Inc. (until Apr 26, 2021); Neuralstem, Inc. (until Jan 23, 2020)
Other Biological Products, (No Diagnostic Substances) companies
- Amgen Inc AMGN
- Gilead Sciences, Inc. GILD
- Moderna, Inc. MRNA
- Argenx SE ARGX
- Revolution Medicines, Inc. RVMD
- Biogen Inc. BIIB
- BioNTech SE BNTX
- Exelixis, Inc. EXEL
All 182 Biological Products, (No Diagnostic Substances) companies
Source: SEC EDGAR filings. This is company-reported data, not investment advice.